MWAL
ABBV icon

Marathon Wealth Advisors LLC’s AbbVie ABBV Stock Holding History

Marathon Wealth Advisors LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.09M Buy
12,292
+110
+0.9% +$23.7K 1.06% 33
2026
Q1 		$2.65M Buy
12,182
+318
+3% +$70.5K 1.09% 33
2025
Q4 		$2.71M Buy
+11,864
New +$2.7M 1.08% 33

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Marathon Wealth Advisors LLC's ABBV Position: Q2 2026 in Review

Marathon Wealth Advisors LLC increased its AbbVie (ABBV) stake by 0.9% in Q2 2026, buying an estimated $23.7K and bringing the position to 12,292 shares worth $3.09M. The position accounts for 1.06% of the portfolio, ranked #33.

Marathon Wealth Advisors LLC first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Marathon Wealth Advisors LLC held 12,292 shares of AbbVie worth $3.09M as of Q2 2026.
  • Marathon Wealth Advisors LLC bought 110 AbbVie shares in Q2 2026, an estimated $23.7K.
  • AbbVie made up 1.06% of Marathon Wealth Advisors LLC's portfolio in Q2 2026, its #33 holding.
  • Marathon Wealth Advisors LLC first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Marathon Wealth Advisors LLC's 13F filing for Q2 2026, filed 11 Sep 2026.